| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |